Delivery Order SPE2DB22D1106-SPE2DB25FFAL9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,040.73 to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets (100-count) on May 12, 2025, with an ultimate completion date of May 13, 2025. This firm fixed-price, non-competitive delivery order represents a single pharmaceutical supply transaction under AmerisourceBergen's broader federal contract portfolio. The product will be delivered to the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,714.19 to AmerisourceBergen Drug Corp for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets (500 count) with a firm fixed price and completion date of August 27, 2025. This non-set-aside competitive award was made to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare solutions provider. The...
- The Defense Logistics Agency awarded a $1,258.58 delivery order to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets (500 count) on July 31, 2025, with completion expected by August 1, 2025. This firm fixed price, competitively awarded delivery order represents a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets in quantities of 100 units. This is a competitively awarded, firm fixed price contract with no set-aside designation, valued at $1,474.20 and scheduled for completion by August 29, 2025. The product will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,043.53 firm fixed price delivery order to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets (100 count) on July 28, 2025, with completion scheduled for July 29, 2025. This competitive award, issued without set-aside designation, is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $4,242.27 delivery order to AmerisourceBergen Drug Corp on May 1, 2025, for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets (100 count). This firm fixed price delivery order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $1,445.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Butalbital-Aspirin-Caffeine tablets (90-count). This non-set-aside contract was awarded competitively and has an ultimate completion date of September 16, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,516.31 to AmerisourceBergen Drug Corp for Butalbital-Aspirin-Caffeine tablets (90-count) on August 18, 2025, with completion scheduled for August 19, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at the company's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, serves as a prime...
- The Defense Logistics Agency awarded a delivery order valued at $2,997.78 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Butalbital-Acetaminophen-Caffeine-Codeine 50-300mg tablets (100 count). This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, represents a competitive award with no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for butalbital-acetaminophen-caffeine with codeine (50-300mg, 100 count) with a ceiling value of $1,254.54 under a firm fixed-price contract type. This award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAL9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,373.17 to AmerisourceBergen Drug Corp for butalbital-acetaminophen-caffeine 50-325-40mg tablets (100 count) on July 29, 2025, with an ultimate completion date of July 30, 2025. This non-set-aside, competitively awarded contract was issued under firm fixed-price terms and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The product being supplied is a combination pharmaceutical used for pain management, indicating this delivery order supports federal medical supply needs. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. AmerisourceBergen is a major pharmaceutical distributor serving as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's extensive federal contract portfolio with DLA demonstrates its capability to supply a comprehensive range of pharmaceutical products across multiple therapeutic domains, positioning it as a key provider within the Defense Logistics Agency's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 7/29/25 |